 | • レポートコード：TPM-DJ110 • 出版社/出版日：Transparency Market Research / 2019年3月22日 • レポート形態：英文、PDF、282ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、人工血管の世界市場について調べ、人工血管の市場規模、市場動向、市場シェア、市場環境、市場予測、関連企業情報などをまとめました。 |
Global Vascular Grafts Market: Overview
Vascular grafts is a medical device that belongs to a specialized class of medical textiles. The primary purpose of a vascular grafts is to act as an artificial conduit for a diseased artery and help to redirect blood flow from one area to another. Presently, synthetic vascular Grafts are most commonly used which are made of either Dacron or Teflon. Increase in incidence of cardiovascular diseases and peripheral diseases is projected to drive demand for vascular grafts.
The global vascular grafts market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, source, size of vascular grafts, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global vascular grafts market.
Global Vascular Grafts Market: Key Segments
In terms of product, the global vascular grafts market has been segmented into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, bypass grafts, and others. In terms of source, the market has been classified into synthetic, biological, and biosynthetic. The synthetic segment has been categorized into polytetrafluethylene (PTFE), polyurethane (PU), Dacron, and others. The biological segment has been divided into bovine vein, saphenous vein, and others. The biosynthetic segment has been bifurcated into ovine collagen with polyester and others. In terms of size of vascular grafts, the global vascular grafts market has been classified into large and small. Based on application, the market has been categorized into coronary artery bypass, aneurysm, vascular occlusion, critical limb ischemia, renal failure, and others. Based on end-user, the global vascular grafts market has been divided into hospitals, ambulatory surgery centers, cardiac catheterization laboratories, specialty clinics, and others.
Global Vascular Grafts Market: Regional Outlook
Geographically, the global vascular grafts market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global vascular grafts market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the report are W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co.KG (Getinge Group), BD, LeMaitre Vascular, Inc., B. Braun Melsungen AG, Cook Medical, Medtronic plc, ArteGrafts, Inc., Vascutek Ltd., Vascular Grafts Solution Ltd., Heat Medical Europe BV, and CryoLife, Inc.
The global vascular Grafts market has been segmented as follows:
Global Vascular Grafts Market, by Product
Endovascular Stent Grafts
Peripheral Vascular Grafts
Hemodialysis Access Grafts
Bypass Grafts
Others
Global Vascular Grafts Market, by Source
Synthetic
Polytetrafluethylene (PTFE)
Polyurethane (PU)
Dacron
Others
Biological
Bovine Vein
Saphenous Vein
Others
Biosynthetic
Ovine Collagen with Polyester
Others
Global Vascular Grafts Market, by Size of Vascular Graft
Large
Small
Global Vascular Grafts Market, by Application
Coronary Artery Bypass
Aneurysm
Vascular Occlusion
Critical Limb Ischemia
Renal Failure
Others
Global Vascular Grafts Market, by End-user
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Specialty Clinics
Others
Global Vascular Grafts Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Assumptions and Acronyms Used
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Evolution/Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increase in the Incidence of Target Diseases
4.3.1.2. Rise in the Number of Lifestyle-related Disorders
4.3.1.3. Increase in the Geriatric Population
4.3.1.4. Shift toward Value-based Health Care Model
4.3.1.5. Increase in Health Care Spending & Improvement in Health Care Infrastructure
4.3.2. Restraints
4.3.2.1. Stringent Regulatory Guidelines
4.3.2.2. Increase in Adverse Effects
4.3.2.3. Rise in Pricing Pressure
4.3.3. Opportunities
4.3.3.1. Rise in Cases of Renal Impairment, Diabetes, and Obesity
4.3.3.2. Increase in the Number of Potential Markets for Commercializing Vascular Grafts
4.3.3.3. Anti-microbial Coated Grafts
4.4. Global Vascular Market Analysis & Forecast, 2018–2026
4.4.1.1. Market Revenue Projections (US$ Mn)
5. Market Overview
5.1. Global Prevalence of Chronic Kidney Diseases
5.2. Global Prevalence of End-stage Renal Disorders (ESRD)
5.3. Patient Data for Dialysis
5.4. Global Prevalence of Cardiovascular Diseases
5.5. Overview of Cryopreservation Technique
5.6. Pipeline Analysis
6. Global Vascular Grafts Market, by Product
6.1. Introduction and Definitions
6.2. Key Findings
6.3. Global Vascular Grafts Market Analysis, by Product
6.4. Global Vascular Grafts Market Forecast, by Product
6.4.1. Endovascular Stent Grafts
6.4.2. Peripheral Vascular Grafts
6.4.3. Hemodialysis Access Grafts
6.4.4. Bypass Grafts
6.4.5. Others
6.5. Global Vascular Grafts Market Attractiveness Analysis, by Product
7. Global Vascular Grafts Market, by Source
7.1. Introduction and Definitions
7.2. Key Findings
7.3. Global Vascular Grafts Market Analysis, by Source
7.4. Global Vascular Grafts Market Forecast, by Source
7.4.1. Synthetic
7.4.1.1. Polytetrafluethylene (PTFE)
7.4.1.2. Polyurethane (PU)
7.4.1.3. Dacron
7.4.1.4. Others
7.4.2. Biological
7.4.2.1. Bovine Vein
7.4.2.2. Saphenous Vein
7.4.2.3. Others
7.4.3. Biosynthetic
7.4.3.1. Ovine Collagen with Polyester
7.4.3.2. Others
7.5. Global Vascular Grafts Market Attractiveness Analysis, by Source
8. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Vascular Grafts Market Analysis, by Size of Vascular Graft
8.4. Global Vascular Grafts Market Value Forecast, by Size of Vascular Graft, 2016–2026
8.4.1. Large
8.4.2. Small
8.5. Global Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft
9. Global Vascular Grafts Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Vascular Grafts Market Analysis, by Application
9.4. Global Vascular Grafts Market Value Forecast, by Application, 2016–2026
9.4.1. Coronary Artery Bypass
9.4.2. Aneurysm
9.4.3. Vascular Occlusion
9.4.4. Critical Limb Ischemia
9.4.5. Renal Failure
9.4.6. Others
9.5. Others Global Vascular Grafts Market Attractiveness Analysis, by Application
10. Global Vascular Grafts Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Global Vascular Grafts Market Analysis, by End-user
10.4. Global Vascular Grafts Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Cardiac Catheterization Laboratories
10.4.4. Specialty Clinics
10.4.5. Others
10.4.6. Others Global Vascular Grafts Market Attractiveness Analysis, by End-user
11. Global Vascular Grafts Market Analysis and Forecast, by Region
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast, by Region, 2016–2026
11.3.1. North America
11.3.2. Europe
11.3.3. Asia Pacific
11.3.4. Latin America
11.3.5. Middle East & Africa
11.4. Global Vascular Grafts Attractiveness Analysis, by Region
12. North America Vascular Grafts Market Analysis and Forecast, by Region
12.1. Key Findings
12.2. North America Vascular Grafts Market Overview
12.3. North America Vascular Grafts Market Value Share Analysis, by Country
12.4. North America Vascular Grafts Market Size and Forecast, by Country
12.4.1. U.S.
12.4.2. Canada
12.5. North America Vascular Grafts Market Value Share Analysis, by Product
12.6. North America Vascular Grafts Market Size and Forecast, by Product
12.6.1. Endovascular Stent Grafts
12.6.2. Peripheral Vascular Grafts
12.6.3. Hemodialysis Access Grafts
12.6.4. Bypass Grafts
12.6.5. Others
12.7. North America Vascular Grafts Market Value Share Analysis, by Source
12.8. North America Vascular Grafts Market Size and Forecast, by Source
12.8.1. Synthetic
12.8.1.1. Polytetrafluethylene (PTFE)
12.8.1.2. Polyurethane (PU)
12.8.1.3. Dacron
12.8.1.4. Others
12.8.2. Biological
12.8.2.1. Bovine Vein
12.8.2.2. Saphenous Vein
12.8.2.3. Others
12.8.3. Biosynthetic
12.8.3.1. Ovine Collagen with Polyester
12.8.3.2. Others
12.9. North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
12.10. North America Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
12.10.1. Large
12.10.2. Small
12.11. North America Vascular Grafts Market Value Share Analysis, by Application
12.12. North America Vascular Grafts Market Size and Forecast, by Application
12.12.1. Coronary Artery Bypass
12.12.2. Aneurysm
12.12.3. Vascular Occlusion
12.12.4. Critical Limb Ischemia
12.12.5. Renal Failure
12.12.6. Others
12.13. North America Vascular Grafts Market Value Share Analysis, by End-User
12.14. North America Vascular Grafts Market Size and Forecast, by End-user
12.14.1. Hospitals
12.14.2. Ambulatory Surgical Centers
12.14.3. Cardiac Catheterization Laboratories
12.14.4. Specialty Clinics
12.14.5. Others
12.15. North America Vascular Grafts Market Size and Forecast, by Market Attractiveness
12.15.1. Product
12.15.2. Source
12.15.3. Size of Vascular Graft
12.15.4. Application
12.15.5. End-user
12.15.6. Country
13. Europe Vascular Grafts Market Analysis and Forecast, by Region
13.1. Key Findings
13.2. Europe Vascular Grafts Market Overview
13.3. Europe Vascular Grafts Market Value Share Analysis, by Country/Sub-region
13.4. Europe Vascular Grafts Market Size and Forecast, by Country/Sub-region
13.4.1. Germany
13.4.2. France
13.4.3. U.K.
13.4.4. Spain
13.4.5. Italy
13.4.6. Rest of Europe
13.5. Europe Vascular Grafts Market Value Share Analysis, by Product
13.6. Europe Vascular Grafts Market Size and Forecast, by Product
13.6.1. Endovascular Stent Grafts
13.6.2. Peripheral Vascular Grafts
13.6.3. Hemodialysis Access Grafts
13.6.4. Bypass Grafts
13.6.5. Others
13.7. Europe Vascular Grafts Market Value Share Analysis, by Source
13.8. Europe Vascular Grafts Market Size and Forecast, by Source
13.8.1. Synthetic
13.8.1.1. Polytetrafluethylene (PTFE)
13.8.1.2. Polyurethane (PU)
13.8.1.3. Dacron
13.8.1.4. Others
13.8.2. Biological
13.8.2.1. Bovine Vein
13.8.2.2. Saphenous Vein
13.8.2.3. Others
13.8.3. Biosynthetic
13.8.3.1. Ovine Collagen with Polyester
13.8.3.2. Others
13.9. Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
13.10. Europe Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
13.10.1. Large
13.10.2. Small
13.11. Europe Vascular Grafts Market Value Share Analysis, by Application
13.12. Europe Vascular Grafts Market Size and Forecast, by Application
13.12.1. Coronary Artery Bypass
13.12.2. Aneurysm
13.12.3. Vascular Occlusion
13.12.4. Critical Limb Ischemia
13.12.5. Renal Failure
13.12.6. Others
13.13. Europe Vascular Grafts Market Value Share Analysis, by End-User
13.14. Europe Vascular Grafts Market Size and Forecast, by End-user
13.14.1. Hospitals
13.14.2. Ambulatory Surgical Centers
13.14.3. Cardiac Catheterization Laboratories
13.14.4. Specialty Clinics
13.14.5. Others
13.15. Europe Vascular Grafts Market Size and Forecast, by Market Attractiveness
13.15.1. Product
13.15.2. Source
13.15.3. Size of Vascular Graft
13.15.4. Application
13.15.5. End-user
13.15.6. Country
14. Asia Pacific Vascular Grafts Market Analysis and Forecast, by Region
14.1. Key Findings
14.2. Asia Pacific Vascular Grafts Market Overview
14.3. Asia Pacific Vascular Grafts Market Value Share Analysis, by Country/Sub-region
14.4. Asia Pacific Vascular Grafts Market Size and Forecast, by Country/Sub-region
14.4.1. China
14.4.2. Japan
14.4.3. India
14.4.4. Australia & New Zealand
14.4.5. Rest of Asia Pacific
14.5. Asia Pacific Vascular Grafts Market Value Share Analysis, by Product
14.6. Asia Pacific Vascular Grafts Market Size and Forecast, by Product
14.6.1. Endovascular Stent Grafts
14.6.2. Peripheral Vascular Grafts
14.6.3. Hemodialysis Access Grafts
14.6.4. Bypass Grafts
14.6.5. Others
14.7. Asia Pacific Vascular Grafts Market Value Share Analysis, by Source
14.8. Asia Pacific Vascular Grafts Market Size and Forecast, by Source
14.8.1. Synthetic
14.8.1.1. Polytetrafluethylene (PTFE)
14.8.1.2. Polyurethane (PU)
14.8.1.3. Dacron
14.8.1.4. Others
14.8.2. Biological
14.8.2.1. Bovine Vein
14.8.2.2. Saphenous Vein
14.8.2.3. Others
14.8.3. Biosynthetic
14.8.3.1. Ovine Collagen with Polyester
14.8.3.2. Others
14.9. Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
14.10. Asia Pacific Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
14.10.1. Large
14.10.2. Small
14.11. Asia Pacific Vascular Grafts Market Value Share Analysis, by Application
14.12. Asia Pacific Vascular Grafts Market Size and Forecast, by Application
14.12.1. Coronary Artery Bypass
14.12.2. Aneurysm
14.12.3. Vascular Occlusion
14.12.4. Critical Limb Ischemia
14.12.5. Renal Failure
14.12.6. Others
14.13. Asia Pacific Vascular Grafts Market Value Share Analysis, by Application
14.14. Asia Pacific Vascular Grafts Market Size and Forecast, by Application
14.14.1. Hospitals
14.14.2. Ambulatory Surgical Centers
14.14.3. Cardiac Catheterization Laboratories
14.14.4. Specialty Clinics
14.14.5. Others
14.15. Asia Pacific Vascular Grafts Market Size and Forecast, by Market Attractiveness
14.15.1. Product
14.15.2. Source
14.15.3. Size of Vascular Graft
14.15.4. Application
14.15.5. End-user
14.15.6. Country/Sub-region
15. Latin America Vascular Grafts Market Analysis and Forecast, by Region
15.1. Key Findings
15.2. Latin America Vascular Grafts Market Overview
15.3. Latin America Vascular Grafts Market Value Share Analysis, by Country/Sub-region
15.4. Latin America Vascular Grafts Market Size and Forecast, by Country/Sub-region
15.4.1. Brazil
15.4.2. Mexico
15.4.3. Rest of Latin America
15.5. Latin America Vascular Grafts Market Value Share Analysis, by Product
15.6. Latin America Vascular Grafts Market Size and Forecast, by Product
15.6.1. Endovascular Stent Grafts
15.6.2. Peripheral Vascular Grafts
15.6.3. Hemodialysis Access Grafts
15.6.4. Bypass Grafts
15.6.5. Others
15.7. Latin America Vascular Grafts Market Value Share Analysis, by Source
15.8. Latin America Vascular Grafts Market Size and Forecast, by Source
15.8.1. Synthetic
15.8.1.1. Polytetrafluethylene (PTFE)
15.8.1.2. Polyurethane (PU)
15.8.1.3. Dacron
15.8.1.4. Others
15.8.2. Biological
15.8.2.1. Bovine Vein
15.8.2.2. Saphenous Vein
15.8.2.3. Others
15.8.3. Biosynthetic
15.8.3.1. Ovine Collagen with Polyester
15.8.3.2. Others
15.9. Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
15.10. Latin America Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
15.10.1. Large
15.10.2. Small
15.11. Latin America Vascular Grafts Market Value Share Analysis, by Application
15.12. Latin America Vascular Grafts Market Size and Forecast, by Application
15.12.1. Coronary Artery Bypass
15.12.2. Aneurysm
15.12.3. Vascular Occlusion
15.12.4. Critical Limb Ischemia
15.12.5. Renal Failure
15.12.6. Others
15.13. Latin America Vascular Grafts Market Value Share Analysis, by End-user
15.14. Latin America Vascular Grafts Market Size and Forecast, by End-user
15.14.1. Hospitals
15.14.2. Ambulatory Surgical Centers
15.14.3. Cardiac Catheterization Laboratories
15.14.4. Specialty Clinics
15.14.5. Others
15.15. Latin America Vascular Grafts Market Size and Forecast, by Market Attractiveness
15.15.1. Product
15.15.2. Source
15.15.3. Size of Vascular Graft
15.15.4. Application
15.15.5. End-user
15.15.6. Country/Sub-region
16. Middle East & Africa Vascular Grafts Market Analysis and Forecast, by Region
16.1. Key Findings
16.2. Middle East & Africa Vascular Grafts Market Overview
16.3. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Country/Sub-region
16.4. Middle East & Africa Vascular Grafts Market Size and Forecast, by Country/Sub-region
16.4.1. GCC Countries
16.4.2. South Africa
16.4.3. Rest of Middle East & Africa
16.5. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Product
16.6. Middle East & Africa Vascular Grafts Market Size and Forecast, by Product
16.6.1. Endovascular Stent Grafts
16.6.2. Peripheral Vascular Grafts
16.6.3. Hemodialysis Access Grafts
16.6.4. Bypass Grafts
16.6.5. Others
16.7. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Source
16.8. Middle East & Africa Vascular Grafts Market Size and Forecast, by Source
16.8.1. Synthetic
16.8.1.1. Polytetrafluethylene (PTFE)
16.8.1.2. Polyurethane (PU)
16.8.1.3. Dacron
16.8.1.4. Others
16.8.2. Biological
16.8.2.1. Bovine Vein
16.8.2.2. Saphenous Vein
16.8.2.3. Others
16.8.3. Biosynthetic
16.8.3.1. Ovine Collagen with Polyester
16.8.3.2. Others
16.9. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
16.10. Middle East & Africa Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
16.10.1. Large
16.10.2. Small
16.11. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Application
16.12. Middle East & Africa Vascular Grafts Market Size and Forecast, by Application
16.12.1. Coronary Artery Bypass
16.12.2. Aneurysm
16.12.3. Vascular Occlusion
16.12.4. Critical Limb Ischemia
16.12.5. Renal Failure
16.12.6. Others
16.13. Middle East & Africa Vascular Grafts Market Value Share Analysis, by End-user
16.14. Middle East & Africa Vascular Grafts Market Size and Forecast, by End-user
16.14.1. Hospitals
16.14.2. Ambulatory Surgical Centers
16.14.3. Cardiac Catheterization Laboratories
16.14.4. Specialty Clinics
16.14.5. Others
16.15. Middle East & Africa Vascular Grafts Market Size and Forecast, by Market Attractiveness
16.15.1. Product
16.15.2. Source
16.15.3. Size of Vascular Graft
16.15.4. Application
16.15.5. End-user
16.15.6. Country/Sub-region
17. Competitive Landscape
17.1. Company Analysis
17.2. Competition Matrix
17.3. Company Profiles
17.3.1. LaMaitre Vascular, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. B. Braun Melsungen AG
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. C. R. Bard, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Cook Medical
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Medtronic plc
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. ArteGrafts, Inc.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Vascutek Ltd.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Vascular Grafts Solution Ltd.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Heart Medical Europe BV
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. W. L. Gore & Associates, Inc.
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
17.3.11. CryoLife, Inc.
17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. SWOT Analysis
17.3.11.5. Strategic Overview
17.3.12. Maquet Holding B.V. & Co. KG
17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.12.2. Financial Overview
17.3.12.3. Product Portfolio
17.3.12.4. SWOT Analysis
17.3.12.5. Strategic Overview
Table 01: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Source, 2016–2026
Table 03: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 04: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Biological, 2016–2026
Table 05: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 06: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 07: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: Global Vascular Grafts Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 11: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 12: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 13: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 14: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 15: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 16: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 17: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: North America Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 21: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 22: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 23: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 24: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 25: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 26: Europe Vascular Grafts Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 27: Europe Vascular Grafts Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 28: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 29: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 31: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 32: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 33: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 34: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 35: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 36: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 37: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 38: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 40: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 41: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 42: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2016–2026
Table 43: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 44: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 45: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 46: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 47: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 48: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 49: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 50: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 51: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 52: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 53: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 54: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026